User profiles for Sara Y. Tartof
 | Sara TartofEpidemiologist/Research Scientist, Kaiser Permanente Southern California Department of … Verified email at kp.org Cited by 6354 |
[HTML][HTML] Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Background Vaccine effectiveness studies have not differentiated the effect of the delta (B.1.617.2)
variant and potential waning immunity in observed reductions in effectiveness against …
variant and potential waning immunity in observed reductions in effectiveness against …
Waning immunity to pertussis following 5 doses of DTaP
SY Tartof, M Lewis, C Kenyon, K White, A Osborn… - …, 2013 - publications.aap.org
OBJECTIVE: To assess the risk of pertussis by time since vaccination in children in Minnesota
and Oregon who received 5 doses of acellular pertussis vaccines (DTaP). METHODS: …
and Oregon who received 5 doses of acellular pertussis vaccines (DTaP). METHODS: …
Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization
SY Tartof, L Qian, V Hong, R Wei… - Annals of internal …, 2020 - acpjournals.org
Background: Obesity, race/ethnicity, and other correlated characteristics have emerged as
high-profile risk factors for adverse coronavirus disease 2019 (COVID-19)–associated …
high-profile risk factors for adverse coronavirus disease 2019 (COVID-19)–associated …
Clinical outcomes associated with SARS-CoV-2 Omicron (B. 1.1. 529) variant and BA. 1/BA. 1.1 or BA. 2 subvariant infection in Southern California
Epidemiologic surveillance has revealed decoupling of Coronavirus Disease 2019 (COVID-19)
hospitalizations and deaths from case counts after emergence of the Omicron (B.1.1.529…
hospitalizations and deaths from case counts after emergence of the Omicron (B.1.1.529…
[HTML][HTML] Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients
Objectives To compare hospitalisation rates, intensive care unit (ICU) admissions and
mortality for patients with COVID-19 who were consistently inactive, doing some activity or …
mortality for patients with COVID-19 who were consistently inactive, doing some activity or …
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a …
SY Tartof, JM Slezak, L Puzniak, V Hong… - The Lancet …, 2022 - thelancet.com
Background The duration of protection against the omicron (B.1.1.529) variant for current
COVID-19 vaccines is not well characterised. Vaccine-specific estimates are especially needed…
COVID-19 vaccines is not well characterised. Vaccine-specific estimates are especially needed…
Analysis of a Uropathogenic Escherichia coli Clonal Group by Multilocus Sequence Typing
SY Tartof, OD Solberg, AR Manges… - Journal of clinical …, 2005 - Am Soc Microbiol
Although many strain typing methods exist for pathogenic Escherichia coli, most have
drawbacks in terms of resolving power, interpretability, or scalability. For this reason, multilocus …
drawbacks in terms of resolving power, interpretability, or scalability. For this reason, multilocus …
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: a retrospective cohort study
SY Tartof, JM Slezak, L Puzniak, V Hong… - The Lancet Regional …, 2022 - thelancet.com
Background Globally, recommendations are expanding for third (booster) doses of
BNT162b2 (Pfizer–BioNTech). In the United States, as of November 19, 2021, boosters were …
BNT162b2 (Pfizer–BioNTech). In the United States, as of November 19, 2021, boosters were …
BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA. 4 and BA. 5
SY Tartof, JM Slezak, L Puzniak, V Hong… - The Lancet Infectious …, 2022 - thelancet.com
Correspondence 1664 www. thelancet. com/infection Vol 22 December 2022 emergency
department encounters only in the first 3 months after a third dose of vaccine (table). At 6 …
department encounters only in the first 3 months after a third dose of vaccine (table). At 6 …
Effectiveness associated with BNT162b2 vaccine against emergency department and urgent care encounters for delta and omicron SARS-CoV-2 infection among …
SY Tartof, TB Frankland, JM Slezak… - JAMA network …, 2022 - jamanetwork.com
Importance Data about the duration of protection of 2 and 3 doses of BNT162b2 in children
and adolescents are needed to help inform recommendations for boosters in this age group. …
and adolescents are needed to help inform recommendations for boosters in this age group. …
